pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
AVA-6103
Adenocarcinoma Of The Gastroesophageal Junction
Avacta Life Sciences Ltd
0
catalysts
Phase 2
AVC-203
Diffuse Large B-Cell Lymphoma
AvenCell Therapeutics Inc
0
catalysts
Phase 2
AVGBM-1
Glioblastoma Multiforme (GBM)
AiVita Biomedical Inc
0
catalysts
Phase 3
AVMEL-1
Melanoma
← prev
page 11 of 62
next →
131
Pain
89
Neurology
1
AiVita Biomedical Inc
0
catalysts
Preclinical
AWAKE-101
Pancreatic Ductal Adenocarcinoma
Loki Therapeutics Inc
0
catalysts
Phase 2
AZD-0120
Refractory Multiple Myeloma
Gracell Biotechnologies Inc
0
catalysts
Phase 3
AZD-1390
Recurrent Glioblastoma Multiforme (GBM)
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
AZD-5863
Adenocarcinoma Of The Gastroesophageal Junction
$AZN
ASTRAZENECA PLC
0
catalysts
Preclinical
Ac-225 BisPSMA
Prostate Cancer
Clarity Pharmaceuticals Ltd
0
catalysts
Phase 2
Activated T Lymphocytes
Hepatocellular Carcinoma
Lukas Biomedical Inc
0
catalysts
Marketed
Acumin
Topotecan Hydrochloride (topotecan hydrochloride)
Small-Cell Lung Cancer
$PFE
PFIZER INC
0
catalysts
Phase 2
AdAPT-001
Chondrosarcoma
EpicentRx Inc
0
catalysts
Preclinical
Adze-1.17.C
Glioblastoma Multiforme (GBM)
Adze Biotechnology Inc
0
catalysts
Preclinical
AiSN Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Theranostec Inc
0
catalysts
Preclinical
Allogeneic CAR-iNKT Product Targeting GPC3
Hepatocellular Carcinoma
Arovella Therapeutics Ltd
0
catalysts
Preclinical
Antisense RNAi Oligonucleotide to Inhibit microRNA-214 for Colon Cancer and Ulcerative Colitis
Colon Cancer
University of California Los Angeles
0
catalysts
Preclinical
Apc-002
Gastric Cancer
Aptacure Therapeutics Ltd
0
catalysts
Preclinical
BA-101
Glioblastoma Multiforme (GBM)
NeuroNOS Ltd
0
catalysts
Preclinical
BA-3142
Head And Neck Cancer
$BCAB
BioAtla, Inc.
0
catalysts
Phase 1
BAL-0891
Adenocarcinoma Of The Gastroesophageal Junction
Sillajen Biotherapeutics
0
catalysts
Phase 2
BAT-8006
Epithelial Ovarian Cancer
Bio-Thera Solutions Ltd
0
catalysts
Phase 2
BB-1701
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Bliss Biopharmaceutical (Hangzhou) Co Ltd
0
catalysts
Preclinical
BB-IO
Unspecified Infectious Diseases
BroadenBio Co Ltd
0
catalysts
Phase 1
BBI-940
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$BOLD
Boundless Bio, Inc.
0
catalysts
Phase 1
BBO-11818
Pancreatic Ductal Adenocarcinoma
$BBOT
BridgeBio Oncology Therapeutics, Inc.
0
catalysts
Phase 1
BBO-8520
Metastatic Colorectal Cancer
$BBOT
BridgeBio Oncology Therapeutics, Inc.
0
catalysts
Phase 2
BBT-207
Non-Small Cell Lung Cancer
Parataxis Korea Inc
0
catalysts
Phase 1
BC-3195
Endometrial Cancer
BioCity Biopharma Co Ltd
0
catalysts
Preclinical
BCB-276
Pediatric Diffuse Intrinsic Pontine Glioma
BrainChild Bio Inc
0
catalysts
Preclinical
BCyIF-1
Solid Tumor
BioCytics
0
catalysts
